218eTiP The PULMO-01 phase I/IIa study of roginolisib in combination with dostarlimab, with or without docetaxel, in patients with advanced non-squamous NSCLC who have progressed on standard of care therapy
Wener R., Azkarate Martinez A., Bearz A. et al
ESMO Open Science for Optimal Cancer Care, 2026
DOI: 10.1016/j.esmoop.2026.106524